PreveCeutical™ Medic
PreveCeutical™ Medical Inc. Launches Phase One of Venom Re-Engineering Project
July 25, 2017 08:30 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, July 25, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the launch of the Company’s multi-faceted Research...
PreveCeutical signs
PreveCeutical signs Research and Option Agreement with UniQuest Pty Limited for Developing Dual-Gene Therapy Treatment for Diabetes and Obesity
July 17, 2017 08:30 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, July 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”)  (CSE:PREV) announces, further to its news release dated April 13, 2017,...
Update: PreveCeutica
Update: PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer
May 17, 2017 16:30 ET | PreveCeutical Medical Inc
**NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES** VANCOUVER, British Columbia, May 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc....
PreveCeutical Announ
PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer
May 17, 2017 09:00 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, May 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women’s Health
April 27, 2017 07:30 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., April 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's healthcare company announced today that a presentation entitled “An Update on Hormonal...
PreveCeutical Signs
PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Extraction, Formulation and Ex Vivo Evaluation of Cannabinoids (“CBD”s) for Delivery via Sol-Gels
April 24, 2017 08:30 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, April 24, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilising nature and science for the benefit of...
PreveCeutical Signs
PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Development of Caribbean Blue Scorpion Venom-Derived Natural & Synthetic Peptides
April 20, 2017 09:00 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, April 20, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...
PreveCeutical Signs
PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest Pty Limited
April 13, 2017 09:00 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, April 13, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of...
PreveCeutical Announ
PreveCeutical Announces Closing of Debt Financing
January 12, 2017 09:00 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, Jan. 12, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. ("PreveCeutical", or the "Company"), a health and wellness company focused on utilizing nature and science...
PreveCeutical Announ
PreveCeutical Announces Filing of Preliminary Prospectus for Initial Public Offering and Private Placement
October 05, 2016 09:30 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, Oct. 05, 2016 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. ("PreveCeutical", or the "Company"), a health and wellness company focused on utilizing nature and science...